Form 4: Ionis Pharmaceuticals Director Joseph Klein III Sells Shares

Director Joseph Klein III of Ionis Pharmaceuticals sold shares of common stock on May 3, 2024, through multiple transactions at varying prices.

Summary

• On May 3, 2024, Joseph Klein III, a director of Ionis Pharmaceuticals, sold shares of the company's common stock.
• The sales were executed through multiple transactions at different price points.
• A total of 16,346 shares were directly owned after the transactions.
• The director also indirectly owns 100 shares through his son.
• The sales were conducted at weighted average prices ranging from approximately $42.55 to $42.98.
• Some shares were sold via a trust.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock sales by a director. The sales themselves don't necessarily indicate a positive or negative outlook.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence in the pharmaceutical industry.

Stakeholder Impact

• The stock sale by a director could have a minor impact on shareholder confidence, but is unlikely to be significant given the volume of shares sold relative to the company's total outstanding shares.

Key Dates